Market Indices
Sector Heatmap
INBX — Inhibrx Biosciences, Inc. Common Stock
NasdaqInhibrx Biosciences, Inc. Common Stock
- O
- 99.30
- H
- 100.13
- L
- 96.07
- V
- 201.44K
INBX — Latest News & Headlines
19 StoriesInhibrx Stock Price Forecast. Should You Buy INBX? - StockInvest.us
Inhibrx Stock Price Forecast. Should You Buy INBX? StockInvest.us
$INBX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative
$INBX stock is down 11% today. Here's what we see in our data. Quiver Quantitative
At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX). - Stock Titan
At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX). Stock Titan
Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? - Simply Wall Street
Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? Simply Wall Street
Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? - Yahoo Finance
Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? Yahoo Finance
Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup - MarketBeat
Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup MarketBeat
Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. - Stock Titan
Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. Stock Titan
Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock - Investing.com
Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock Investing.com
Inhibrx Biosciences (INBX) Faces A Pipeline Valuation Test Following Its Sharp Rerating - Yahoo Finance
Inhibrx Biosciences (INBX) Faces A Pipeline Valuation Test Following Its Sharp Rerating Yahoo Finance
Inhibrx Biosciences stock gains on insider buying and trial progress - AD HOC NEWS
Inhibrx Biosciences stock gains on insider buying and trial progress AD HOC NEWS
Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing - marketscreener.com
Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing marketscreener.com
INBX Oct 2026 90.000 put (INBX261016P00090000) Stock Price, News, Quote & History - ca.finance.yahoo.com
INBX Oct 2026 90.000 put (INBX261016P00090000) Stock Price, News, Quote & History ca.finance.yahoo.com
A bone cancer drug met its trial goal for Inhibrx Biosciences (INBX), delaying progression versus placebo. - Stock Titan
A bone cancer drug met its trial goal for Inhibrx Biosciences (INBX), delaying progression versus placebo. Stock Titan
Inhibrx updates pipeline data as analysts rate Inhibrx stock Moderate Buy - AD HOC NEWS
Inhibrx updates pipeline data as analysts rate Inhibrx stock Moderate Buy AD HOC NEWS
CPB,AHRT,NPWR,BSIN,INBX,VRSK,AMPG | Stock Prices | Quote Comparison - ca.finance.yahoo.com
CPB,AHRT,NPWR,BSIN,INBX,VRSK,AMPG | Stock Prices | Quote Comparison ca.finance.yahoo.com
Inhibrx Biosciences stock falls 1.62 percent on October 5 - AD HOC NEWS
Inhibrx Biosciences stock falls 1.62 percent on October 5 AD HOC NEWS
Inhibrx Biosciences stock reports stronger cancer study data - AD HOC NEWS
Inhibrx Biosciences stock reports stronger cancer study data AD HOC NEWS
Inhibrx Biosciences stock gets a Moderate Buy consensus at USD 197.50 - AD HOC NEWS
Inhibrx Biosciences stock gets a Moderate Buy consensus at USD 197.50 AD HOC NEWS
Inhibrx Biosciences Updates Investor Presentation and Pipeline Outlook - TipRanks
Inhibrx Biosciences Updates Investor Presentation and Pipeline Outlook TipRanks